Johnson & Johnson MedTech Presents 3-Month Data from Omny-IRE Clinical Trial at 2025 Heart Rhythm Society Annual Meeting

Johnson & Johnson MedTech Presents 3-Month Data from Omny-IRE Clinical Trial at 2025 Heart Rhythm Society Annual Meeting

Omny-IRE data demonstrated the investigational OMNYPULSE™ Platform achieved 100% acute success and 84.5% pulmonary vein isolation (PVI) durability at three months, with promising safety outcomes1

Johnson & Johnson and OMP present blueprint for supply chain transformation at Gartner Supply Chain Symposium/Xpo in Orlando

ORLANDO, Fla., April 25, 2025 (Ecnetnews.com) – OMP, a leading provider of supply chain planning solutions, invites attendees of the Gartner Supply Chain Symposium/Xpo 2025 to attend Johnson & Johnson’s featured session. The presentation will highlight how the J&J Innovative Medicine division is transforming its supply chain to tackle global challenges using OMP’s Unison Planning. In this session, Joseph Bitterman, Vice President of Supply Chain…